NASDAQ · ATEC
Healthcare · Medical - Devices
$7.04
Down-$4.33 (-38.08%)
Updated Oct 31, 2026, 9:21 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ATEC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
ATEC closed at $7.04 after 21 trading sessions, down 29.81% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $6.855 | $8.015 | $6.81 | $7.04 | 27.73M |
| Oct 29, 2026 | $11.67 | $12.195 | $11.29 | $11.37 | 7.22M |
| Oct 28, 2026 | $10.80 | $11.565 | $10.80 | $11.45 | 4.55M |
| Oct 27, 2026 | $10.925 | $11.06 | $10.67 | $10.87 | 3.9M |
| Oct 26, 2026 | $11.13 | $11.15 | $10.88 | $10.90 | 3.16M |
| Oct 23, 2026 | $11.27 | $11.45 | $11.09 | $11.11 | 3.28M |
| Oct 22, 2026 | $10.87 | $11.595 | $10.87 | $11.36 | 3.18M |
| Oct 21, 2026 | $10.72 | $11.10 | $10.72 | $10.86 | 1.69M |
| Oct 20, 2026 | $10.57 | $10.975 | $10.41 | $10.86 | 1.45M |
| Oct 19, 2026 | $10.42 | $10.5399 | $10.35 | $10.41 | 1.58M |
| Oct 16, 2026 | $10.93 | $11.14 | $10.405 | $10.46 | 2.7M |
| Oct 15, 2026 | $10.59 | $10.966 | $10.46 | $10.93 | 3.05M |
| Oct 14, 2026 | $10.63 | $10.81 | $10.31 | $10.44 | 1.76M |
| Oct 13, 2026 | $11.30 | $11.54 | $10.795 | $10.82 | 2.32M |
| Oct 12, 2026 | $10.69 | $11.26 | $10.69 | $11.25 | 2.95M |
| Oct 9, 2026 | $10.38 | $10.745 | $10.32 | $10.67 | 1.57M |
| Oct 8, 2026 | $10.15 | $10.40 | $10.06 | $10.35 | 2.64M |
| Oct 7, 2026 | $10.41 | $10.66 | $10.175 | $10.25 | 2.44M |
| Oct 6, 2026 | $10.77 | $10.89 | $10.49 | $10.54 | 1.91M |
| Oct 5, 2026 | $9.98 | $10.75 | $9.94 | $10.72 | 2.06M |
| Oct 2, 2026 | $10.10 | $10.175 | $9.80 | $10.03 | 2.19M |
The latest Smart Investors Daily articles mentioning ATEC.
Company
Market Activity
Research & News
ATEC research
Company profile and research snapshot.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Needham | Buy | — |
| Aug 5, 2026 | UBS | Buy | — |
| Aug 5, 2026 | TD Cowen | Buy | — |
| Aug 5, 2026 | BMO Capital | Outperform | — |
| Jul 28, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 30, 2026
Patrick's purchase brings his total beneficial ownership to 6.2 million shares worth $54.41 million, signaling confidence despite the stock's 42% decline over the past year.
Yahoo · Jan 30, 2026
Alphatec Holdings Inc. (NASDAQ:ATEC) is one of the best high short interest stocks with biggest upside potential. On January 27, TD Cowen lowered its price target for Alphatec to $20 from $27 while maintaining a Buy rating following a transfer of coverage. The firm suggested that the current market expectations do not fully appreciate the […]
SeekingAlpha · Jan 25, 2026
SeekingAlpha · Jan 14, 2026
Alphatec Holdings, Inc. (ATEC) 44th Annual J.P.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ATEC.
